Book icon with persian name of Pubnito
StoreLibrary

Your Cart


Total Items:0

Israel Valencia Quiroz

Prof. Israel Valencia Quiroz is a renowned biotechnology scholar and associate professor at the Laboratory of Phytochemistry, UBIPRO, FES Iztacala, UNAM, México.

Israel Valencia Quiroz

Top selling books

You may also be interested in these books written by the same author

Biotechnology and Drug Development for Targeting Human Diseases

available format

EPUB

Biotechnology and Drug Development for Targeting Human Diseases

Israel Valencia Quiroz

$ 59.00

Most Popular

Biotechnology and Drug Development for Targeting Human Diseases

"Biotechnology and Drug Development for Targeting Human Diseases is an insightful compendium on drug development technologies for professionals and students in biotechnology and pharmacology. This book meticulously explores the intersection of biotechnology with drug development, emphasizing its crucial role in creating new therapies for human disease. Central to the book is the innovative use of biotechnology in understanding and treating diseases. It begins with an exploration of multi-omics profiles, shedding light on disease mechanisms and drug development. Subsequent chapters explain in silico methods for drug design, the role of natural products in antimicrobial applications and wound healing, and the use of viruses as carriers in biotechnology. Key features of this reference include a blend of theoretical knowledge and practical insights, detailed analyses of molecular docking in drug discovery, the repurposing of drugs for various diseases, and the emerging field of omics technologies in drug interaction studies. Each chapter is comprehensive, offering current information backed by extensive references, making the book both a foundational and advanced resource. Readership Students and professionals in the fields of biotechnology and pharmacology."

Books List

You may also be interested in the other books in this section
logo

English

Powered by PUBNiTO | © 2024 Notion Wave Inc.